Cubist Sets Sights On European Antibiotics Market With Zurich Move: A Conversation With Patrick Vink
Executive Summary
Cubist recently has seen its key antibiotic Cubicin become a blockbuster in the U.S. It is determined to take this success, backed by a flourishing pipeline, to answer Europe's call for products to fight antimicrobial resistance.